{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:12:42Z","timestamp":1766013162688,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00393-024-01607-7","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T20:42:52Z","timestamp":1734036172000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still\u2019s disease in Germany","Umsetzung der neuen DGRh-S2e-Leitlinie zur Diagnostik und Therapie des adulten Still-Syndroms in Deutschland"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1642-8764","authenticated-orcid":false,"given":"Rhea","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kernder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-6243","authenticated-orcid":false,"given":"Diana","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Key\u00dfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-7790","authenticated-orcid":false,"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8517-616X","authenticated-orcid":false,"given":"Anna","family":"Meinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schomburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Vordenb\u00e4umen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-5282","authenticated-orcid":false,"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"8","key":"1607_CR1","first-page":"e10008","volume":"12","author":"S Hassan","year":"2020","unstructured":"Hassan\u00a0S, Choudhry\u00a0A, Jamal\u00a0S, Sheikh\u00a0F, Farooque\u00a0U (2020) Adult onset still\u2019s disease: a\u00a0retrospective, single-center study. Cureus 12(8):e10008","journal-title":"Cureus"},{"issue":"1","key":"1607_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-022-01276-4","volume":"81","author":"S Vordenb\u00e4umen","year":"2022","unstructured":"Vordenb\u00e4umen\u00a0S, Feist\u00a0E, Rech\u00a0J, Fleck\u00a0M, Blank\u00a0N, Haas\u00a0JP, K\u00f6tter\u00a0I, Krusche\u00a0M, Chehab\u00a0G, Hoyer\u00a0B, Kiltz\u00a0U, Fell\u00a0D, Reiners\u00a0J, Weseloh\u00a0C, Schneider\u00a0M, Braun\u00a0J (2022) DGrh S2e guidelines: diagnostic and treatment of adult-onset still\u2019s disease (AOSD). Z\u00a0Rheumatol 81(1):1\u201320","journal-title":"Z Rheumatol"},{"key":"1607_CR3","doi-asserted-by":"crossref","unstructured":"Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Anton J, Belot A, Bracaglia C, Constantin T, Dagna L, de Bartolo A, Feist E, Foell D, Gattorno M, Georgin-Lavialle S, Giacomelli R, Grom A, Jamilloux Y, Laskari K, Lazar C, Minoia F, Nigrovic P, Oliveira Ramos F, Ozen S, Quartier Dit MP, Ruscitti P, Sag E, Savic S, Truchetet M, Vastert S, Wilhelmer T, Wouters C, Carmona L, De Benedetti F (2023) EULAR \/ preS recommendations for the diagnosis and management of systemic juvenile idiopathic arthritis (sJIA) and adult onset still\u2019s disease (AOSD). Arthritis Rheumatol 75(9)","DOI":"10.1136\/ard-2024-225851"},{"issue":"3","key":"1607_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbspin.2017.05.011","volume":"85","author":"S Mitrovic","year":"2018","unstructured":"Mitrovic\u00a0S, Fautrel\u00a0B (2018) New markers for adult-onset still\u2019s disease. Joint Bone Spine 85(3):285\u2013293","journal-title":"Joint Bone Spine"},{"key":"1607_CR5","unstructured":"https:\/\/open.fau.de\/server\/api\/core\/bitstreams\/19154b60-180f-42e4-9fc0-1fb6cfb1bfe0\/content. Accessed 5 Sept 2024"},{"issue":"10","key":"1607_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Mitrovic\u00a0S, Fautrel\u00a0B (2018) Mechanisms, biomarkers and targets for adult-onset still\u2019s disease. Nat Rev Rheumatol 14(10):603\u2013618","journal-title":"Nat Rev Rheumatol"},{"key":"1607_CR7","first-page":"317820","volume":"2012","author":"C Giampietro","year":"2012","unstructured":"Giampietro\u00a0C, Fautrel\u00a0B (2012) Anti-Interleukin\u20111 agents in adult onset still\u2019s disease. Int J Inflam 2012:317820","journal-title":"Int J Inflam"},{"key":"1607_CR8","first-page":"S64","volume":"34","author":"ST Song","year":"2016","unstructured":"Song\u00a0ST, Kim\u00a0JJ, Lee\u00a0S, Kim\u00a0HA, Lee\u00a0EY, Shin\u00a0KC, Lee\u00a0JH, Lee\u00a0KH, Choi\u00a0ST, Cha\u00a0HS, Yoo\u00a0DH (2016) Efficacy of tocilizumab therapy in Korean patients with adult-onset still\u2019s disease: a\u00a0multicentre retrospective study of 22\u00a0cases. Clin Exp Rheumatol 34:S64\u2013S71","journal-title":"Clin Exp Rheumatol"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","volume":"7","author":"T Li","year":"2017","unstructured":"Li\u00a0T, Gu\u00a0L, Wang\u00a0X, Guo\u00a0L, Shi\u00a0H, Yang\u00a0C, Chen\u00a0S (2017) A pilot study on tocilizumab for treating refractory adult-onset still\u2019s disease. Sci Rep 7:13477","journal-title":"Sci Rep"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/1744666X.2018.1465821","volume":"14","author":"S Mitrovic","year":"2018","unstructured":"Mitrovic\u00a0S, Fautrel\u00a0B (2018) Complications of adult-onset still\u2019s disease and their management. Expert Rev Clin Immunol 14:351\u2013365","journal-title":"Expert Rev Clin Immunol"},{"key":"1607_CR11","doi-asserted-by":"publisher","first-page":"e7955","DOI":"10.1002\/ccr3.7955","volume":"11","author":"A Ahmadzadeh","year":"2023","unstructured":"Ahmadzadeh\u00a0A, Babadi\u00a0N, Farsad\u00a0F, Babadi\u00a0S, Assar\u00a0S (2023) Hemophagocytic lymphohistiocytosis accompanying still\u2019s disease: a\u00a0case report. Clin Case Rep 11:e7955","journal-title":"Clin Case Rep"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot\u00a0A, Toh\u00a0ML, Copp\u00e9r\u00e9\u00a0B, Perard\u00a0L, Madoux\u00a0GMH, Mausservey\u00a0C, Desmurs-Clavel\u00a0H, Ffrench\u00a0M, Ninet\u00a0J (2010) Reactive hemophagocytic syndrome in adult-onset still disease: clinical features and long-term outcome: a\u00a0case-control study of 8\u00a0patients. Medicine 89:37\u201346","journal-title":"Medicine"},{"key":"1607_CR13","first-page":"401","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan\u00a0AV, Schneider\u00a0R (2003) Macrophage activation syndrome following initiation of etanercept in a\u00a0child with systemic onset juvenile rheumatoid arthritis. J\u00a0Rheumatol 30:401\u2013403","journal-title":"J Rheumatol"},{"issue":"3","key":"1607_CR14","first-page":"RA27","volume":"14","author":"AG Tristano","year":"2008","unstructured":"Tristano\u00a0AG (2008) Macrophage activation syndrome: a\u00a0frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit 14(3):RA27\u2013RA36","journal-title":"Med Sci Monit"},{"issue":"6","key":"1607_CR15","first-page":"517","volume":"80","author":"CA Silva","year":"2004","unstructured":"Silva\u00a0CA, Silva\u00a0CH, Robazzi\u00a0TC, Lotito\u00a0AP, Mendroni\u00a0JA, Jacob\u00a0CM, Kiss\u00a0MH (2004) S\u00edndrome de ativa\u00e7\u00e3o macrof\u00e1gica associada com artrite idiop\u00e1tica juvenil sist\u00eamica.\u00a0(Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis) An Pediatr 80(6):517\u2013522","journal-title":"An Pediatr"},{"key":"1607_CR16","first-page":"623","volume":"31","author":"H Sawar","year":"2004","unstructured":"Sawar\u00a0H, Espinoza\u00a0LR, Gedalia\u00a0A (2004) Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis. J\u00a0Rheumatol 31:623","journal-title":"J Rheumatol"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/1756-185X.12324","volume":"17","author":"S Kadavath","year":"2014","unstructured":"Kadavath\u00a0S, Zapantis\u00a0E, Zolty\u00a0R, Efthimiou\u00a0P (2014) A novel therapeutic approach in pulmonary arterial hypertension as a\u00a0complication of adult-onset still\u2019s disease: targeting IL\u20116. Int J Rheum Dis 17:336\u2013340","journal-title":"Int J Rheum Dis"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12890-016-0237-x","volume":"16","author":"L Guielleminault","year":"2016","unstructured":"Guielleminault\u00a0L, Laurent\u00a0S, Foucher\u00a0A, Poubeau\u00a0P, Paganin\u00a0F (2016) Pulmonary arterial hypertension in adult onset still\u2019s disease: a\u00a0case report of a\u00a0severe complication. BMC Pulm Med 16:72","journal-title":"BMC Pulm Med"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou\u00a0P, Kadavath\u00a0S, Mehta\u00a0B (2014) Life-threatening complications of adult-onset still\u2019s disease. Clin Rheumatol 33:305\u2013314","journal-title":"Clin Rheumatol"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.semarthrit.2019.04.004","volume":"49","author":"BY Mehta","year":"2019","unstructured":"Mehta\u00a0BY, Ibrahim\u00a0S, Briggs\u00a0W, Efthimiou\u00a0P (2019) Racial\/ethnic variations in morbidity and mortality in adult onset still\u2019s disease: an analysis of national dataset. Semin Arthritis Rheum 49:469\u2013473","journal-title":"Semin Arthritis Rheum"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.3390\/jcm10194544","volume":"10","author":"C Borciuch","year":"2021","unstructured":"Borciuch\u00a0C, Fauvernier\u00a0M, Gerfaud-Valentin\u00a0M, S\u00e8ve\u00a0P, Jamilloux\u00a0Y (2021) Still\u2019s disease mortality trends in France, 1979\u20132016: a\u00a0multiple-cause-of-death study. J\u00a0Clin Med 10:4544","journal-title":"J Clin Med"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"e15123","DOI":"10.1097\/MD.0000000000015123","volume":"98","author":"P Ruscitti","year":"2019","unstructured":"Ruscitti\u00a0P, Cipriani\u00a0P, Liakouli\u00a0V, Guggino\u00a0G, Carubbi\u00a0F, Berardicurti\u00a0O, Ciccia\u00a0F, Giacomelli\u00a0R (2019) Managing adult-onset still\u2019s disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study. Medicine 98:e15123","journal-title":"Medicine"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/978-3-642-87014-9_13","volume-title":"Hormone und psyche die Endokrinologie des Alternden menschen. Symposion der Deutschen Gesellschaft f\u00fcr Endokrinologie","author":"C Dieck","year":"1958","unstructured":"Dieck\u00a0C (1958) Psychische Wirkungen und Nebenwirkungen von ACTH und Cortison. In: Nowakowski\u00a0H (ed) Hormone und psyche die Endokrinologie des Alternden menschen. Symposion der Deutschen Gesellschaft f\u00fcr Endokrinologie, Vol 5. Springer, Berlin\/Heidelberg, pp\u00a076\u201377"},{"issue":"4","key":"1607_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00393-021-00972-x","volume":"80","author":"G Key\u00dfer","year":"2021","unstructured":"Key\u00dfer\u00a0G (2021) Sicherheitsaspekte der Therapie mit Glukokortikoiden bei rheumatoider arthritis. (Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis) Z\u00a0Rheumatol 80(4):295\u2013304","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01607-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01607-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01607-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:22:49Z","timestamp":1738160569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01607-7"}},"subtitle":["Implications for clinical practice in rheumatology","Auswirkungen auf die klinische Praxis in der Rheumatologie"],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01607-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"5 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.\u00a0Friedrich declares that there is no conflict of interest. The study was funded by a\u00a0DGRh scholarship (Maja-V\u00f6lkel-Promotionsstipendium). A.\u00a0Kernder received consulting\/speaker fees from Chugai Pharma and Novartis. E.\u00a0Feist received consulting\/speaker fees from Abbvie, BMS, Celgene, Galapagos, Lilly, Medac, Novartis, Roche, Sanofi, Sobi, Pfizer, and UCB. S.\u00a0Vordenb\u00e4umen received speaker fees from Sobi. J.\u00a0Henes received consulting\/speaker fees from Abbvie, BMS, GSK, Novartis, Roche, Sobi, Pfizer, and UCB. J.\u00a0Rech received consulting\/speaker fees from Abbvie, Biogen, BMS, Chugai, GSK, Janssen, Lilly, MSD, Novartis, Roche, Sanofi, Sobi, and UCB and a\u00a0scientific grant from Novartis and Sobi. M.\u00a0Krusche received consulting\/speaker fees from Abbvie, BMS, Pfizer, Alphasigma, Lilly, Medac, Novartis, Roche, Sanofi, and Sobi. N.\u00a0Blank, D.\u00a0Ernst, G.\u00a0Key\u00dfer, P.\u00a0Klemm, A.\u00a0Meinecke, N.\u00a0Schulz, and D.\u00a0Schomburg declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}